2024 greatest T1D hits: A glance at this year’s achievements
While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures and improving everyday life with T1D. This wouldn’t have been possible without each and every one of you and your continued support of our mission as we drive toward cures for T1D. Here are the […]
FDA Advisory Committee does not recommend that sotagliflozin receive approval for glucose lowering in adults with type 1 diabetes (T1D) and Chronic Kidney Disease (CKD)
Update – November 22, 2024 This morning, Lexicon Pharmaceuticals, Inc. (Lexicon) announced they received a “deficiencies preclude discussion” letter from the FDA regarding this drug application. The FDA is not approving sotagliflozin for use in glucose control in people with T1D and CKD and there will be no further discussion in regards to this application. […]
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
A Complication of Type 1: Gastroparesis
Gastroparesis is a condition when the stomach is unable to empty itself properly, leading to problems such as becoming full too early, nausea, and vomiting.
Breakthrough T1D Staff Share Personal Stories About Diabetic Eye Disease
Breakthrough T1D staff share their experiences with diabetic eye disease to help raise awareness of the importance of being proactive when it comes to vision health.
Interview: I’ve Got Hope Back in my Life
The Mary Tyler Moore Vision Initiative has a lofty goal: To halt and reverse vision loss from diabetes. Here’s one woman’s hope for a clearer future.
Moonshot Reimagined: Our Vision to Halt and Reverse Vision Loss
Breakthrough T1D has taken a bold new step to prevent and restore vision loss and blindness: Restoring Vision Moonshot, in honor of Mary Tyler Moore.
100, 100: Ending Diabetic Eye Disease, Forever
Breakthrough T1D has supported eye disease research since its beginning, and has driven discoveries that have reduced the risk of blindness by 95%.
Two Studies Shed Light on Diabetic Kidney Disease
Two recent publications shed light on which people with type 1 diabetes will develop end-stage kidney disease, a complication of diabetes.
50+ Years with Type 1: An Interview with Dr. George King
I got the privilege of interviewing George King, M.D., whose research is on diabetes complications. Breakthrough T1D has funded him since he was early in his career.
